Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/1603
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDe Mel, W.C.P.
dc.contributor.authorNanayakkara, L.S.H.
dc.contributor.authorKarunanayake, R.
dc.contributor.authorSheriff, M.H.R.
dc.contributor.authorDharmadasa, K.
dc.date.accessioned2012-01-04T03:54:21Z
dc.date.available2012-01-04T03:54:21Z
dc.date.issued1985
dc.identifier.citationSri Lanka Medical Association - 98th Anniversary Academic Sessions;1985_.20-21ppen_US
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/1603-
dc.description.abstractSpecific therapy of glomerulonephritis has been far from satisfactory. Twelve patients with biopsy proven membrano-proliferative glomerulonephritis were treated with the combination of warfarin. dipyridamole and cyclophosphamide with or without prednisolone as recommended by an Australian group at the Royal Melbourne university. Of these patients six showed clinical and Biochemical remmision and are now well enough to be gainfully employed. Two have had relapses with recurrent hospitalization. Four of the patients progressed to chronic renal failure and three of them have died during this 5 year follow up period. We have also noticed a relationship between the reduction in 24 hour urinary protein excretion after therapy and the prognosis.
dc.language.isoenen_US
dc.titleA follow-up study of a specific treatment regimen for membrano-proliferative glomerulonephritisen_US
dc.typeResearch abstracten_US
Appears in Collections:Department of Clinical Medicine

Files in This Item:
File Description SizeFormat 
risvi.doc23 kBMicrosoft WordView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.